¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)
Global Cervical Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
»óǰÄÚµå : 1448642
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 253 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,562,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,712,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,543,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ¼ö¿ä´Â 2023³â 59¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2032³â¿¡´Â ¾à 101¾ï 4,000¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ 2024³âºÎÅÍ 2032³â±îÁö CAGRÀº 6.12%·Î Àü¸ÁµË´Ï´Ù.

ÀڱðæºÎ¾Ï Áø´Ü¿¡´Â ÀϹÝÀûÀ¸·Î ÆË½º¸Þ¾î³ª HPV °Ë»ç µîÀÇ ½ºÅ©¸®´× °Ë»ç¿¡ ÀÇÇÑ ÀڱðæºÎÀÇ ÀÌ»óÀÇ µ¿Á¤ ¹× Æò°¡°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Áø´ÜÀº Á¶±â ¹ß°ß¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç ÀڱðæºÎ¾ÏÀ» ¿¹¹æÇϰųª Ä¡·áÇϱâ À§ÇÑ Àû½Ã¿¡ ÀÇ·á °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÄÝÆ÷½ºÄ«ÇÇ ¹× ºÐÀÚ °Ë»ç¿Í °°Àº ÷´Ü ±â¼úÀº Áø´Ü Á¤È®µµ¸¦ ³ôÀÌ°í ¿©¼ºÀÇ °Ç°­ »óÅ °³¼±¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀåÀº ÀڱðæºÎ¾Ï Áø´Ü¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í, ¼¼°èÀÇ ÀڱðæºÎ¾Ï ÀÌȯÀ²ÀÇ »ó½Â, Áø´Ü ¹æ¹ýÀÇ ±â¼úÀû Áøº¸ µîÀÇ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. Á¤±âÀûÀÎ °ËÁø°ú Á¶±â ¹ß°ßÀ» ÃßÁøÇÏ´Â ÀÇ·á±â°üÀ̳ª Á¤ºÎ¿¡ ÀÇÇÑ ÀÌ´Ï¼ÅÆ¼ºêÀÇ °íÁ¶°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºÐÀÚÁø´Ü, HPV °Ë»ç, ¾×ü ¼¼Æ÷ Áø´Ü ±â¼úÀÇ Ã¤¿ëÀº ÀڱðæºÎ¾Ï Áø´ÜÀÇ Á¤È®¼º°ú È¿À²À» ³ôÀÔ´Ï´Ù. ¶ÇÇÑ ¿©¼ºÀÇ °Ç°­¿¡ ÃÊÁ¡À» ¸ÂÃá ±³À° Ä·ÆäÀÎÀÌ ¿¹¹æ ÀÇ·á Á¶Ä¡¸¦ Àå·ÁÇÕ´Ï´Ù. Áø´Ü °úÁ¤¿¡¼­ AI¿Í ÀÚµ¿È­ÀÇ ÅëÇÕÀº ÀýÂ÷¸¦ ´õ¿í °£¼ÒÈ­Çϰí ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀڱðæºÎ¾Ï Áø´Ü »ê¾÷ÀÇ ¼ºÀå ¹× µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡º° ¹× Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ÆÄ¾ÇÇϰí ÇâÈÄ ºñÁî´Ï½º ±âȸ¿¡ µµ¿òÀ» ÁÙ ¼ö ÀÖ½À´Ï´Ù.

À¯Çüº°

¿¬·ÉÃþº°

¿ëµµº°

Áö¿ª ºÐ¼®

ÀÌ ºÎ¹®¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ôÇϽʽÿÀ. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀڱðæºÎ¾Ï Áø´Ü-»ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ºÐ¼® : ¿¬·ÉÃþº°

Á¦7Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ ÀڱðæºÎ¾Ï Áø´Ü ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå ÀڱðæºÎ¾Ï Áø´Ü ±â¾÷ °æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for Cervical Cancer Diagnostics Market is presumed to reach the market size of nearly USD 10.14 Billion by 2032 from USD 5.94 Billion in 2023 with a CAGR of 6.12% under the study period 2024 - 2032.

Cervical cancer diagnostics involve the identification and assessment of abnormalities in the cervix, typically through screening tests like Pap smears and HPV testing. These diagnostics play a crucial role in early detection, allowing for timely medical intervention to prevent or treat cervical cancer. Advanced technologies, such as colposcopy and molecular testing, enhance diagnostic accuracy, contributing to improved women's health outcomes.

MARKET DYNAMICS

The cervical cancer diagnostics market is propelled by factors such as increasing awareness of cervical cancer screening, rising incidences of cervical cancer globally, and technological advancements in diagnostic methods. Growing initiatives by healthcare organizations and governments to promote regular screenings and early detection contribute to market expansion. The adoption of molecular diagnostics, HPV testing, and liquid-based cytology techniques enhances the accuracy and efficiency of cervical cancer diagnosis. Additionally, a focus on women's health, coupled with educational campaigns, encourages preventive healthcare measures. The integration of AI and automation in diagnostic processes further streamlines procedures, fostering growth in the cervical cancer diagnostics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cervical cancer diagnostics. The growth and trends of cervical cancer diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cervical cancer diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

By Age Group

By End Use

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cervical Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cervical Cancer Diagnostics market include Abbott Laboratories, Quigan NV, Thermo Fisher Scientific Inc, Carl Zeiss AG, Dickinson and Company, Hologic Inc, CooperSurgical Inc, Siemens Healthineers. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

2 . EXECUTIVE SUMMARY

3 . CERVICAL CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

4 . VALUE CHAIN ANALYSIS

5 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY TYPE

6 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY AGE GROUP

7 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY END USE

8 . GLOBAL CERVICAL CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

9 . COMPETITIVE LANDSCAPE OF THE CERVICAL CANCER DIAGNOSTICS COMPANIES

10 . COMPANY PROFILES OF CERVICAL CANCER DIAGNOSTICS INDUSTRY

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â